Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Non-Hodgkin Lymphoma (All Stages^), 2013-2017

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Rate
State
 sort alphabetically by name ascending
Met Healthy People Objective of ***?
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate ascending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Recent Trend
Recent 5-Year Trend in Incidence Rates
(95% Confidence Interval)
 sort by trend descending
US (SEER+NPCR) 1 *** 19.3 (19.2, 19.3) N/A 70,661 falling falling trend -1.5 (-2.3, -0.6)
Florida 6 *** 23.8 (23.6, 24.1) 1 (1, 1) 6,493 stable stable trend -4.7 (-10.1, 1.0)
New Jersey 7 *** 21.8 (21.3, 22.2) 2 (2, 7) 2,272 stable stable trend 0.0 (-0.2, 0.1)
New York 7 *** 21.7 (21.4, 21.9) 3 (2, 6) 4,983 stable stable trend -0.4 (-0.8, 0.0)
Minnesota 6 *** 21.3 (20.8, 21.8) 4 (2, 12) 1,345 falling falling trend -1.5 (-3.0, -0.1)
Iowa 7 *** 21.1 (20.5, 21.8) 5 (2, 14) 792 falling falling trend -1.4 (-2.7, -0.2)
Connecticut 7 *** 21.1 (20.5, 21.7) 6 (2, 14) 935 stable stable trend -0.1 (-0.3, 0.2)
Pennsylvania 6 *** 21.0 (20.7, 21.4) 7 (3, 12) 3,424 stable stable trend -2.1 (-4.2, 0.0)
New Hampshire 6 *** 20.9 (19.9, 21.9) 8 (2, 22) 354 stable stable trend -0.1 (-0.9, 0.6)
Wisconsin 6 *** 20.7 (20.2, 21.2) 9 (4, 15) 1,435 stable stable trend 0.1 (-0.3, 0.6)
Maine 6 *** 20.6 (19.7, 21.6) 10 (2, 23) 378 stable stable trend -0.4 (-0.9, 0.1)
Nebraska 6 *** 20.5 (19.6, 21.4) 11 (2, 23) 442 stable stable trend -0.3 (-0.9, 0.3)
Vermont 6 *** 20.3 (18.8, 21.8) 12 (2, 34) 165 stable stable trend -6.5 (-12.8, 0.2)
Delaware 6 *** 20.2 (19.1, 21.4) 13 (2, 30) 238 stable stable trend -4.5 (-9.3, 0.6)
Kentucky 7 *** 20.1 (19.6, 20.7) 14 (8, 22) 1,043 stable stable trend 0.1 (-0.4, 0.5)
Rhode Island 6 *** 20.1 (19.0, 21.2) 15 (2, 31) 261 stable stable trend -8.4 (-16.8, 0.9)
Michigan 5 *** 19.7 # (19.3, 20.0) 16 (12, 25) 2,356 falling falling trend -0.9 (-1.4, -0.4)
Washington 5 *** 19.6 (19.2, 20.1) 17 (11, 26) 1,574 falling falling trend -1.3 (-1.5, -1.0)
Illinois 6 *** 19.5 (19.2, 19.8) 18 (13, 26) 2,818 stable stable trend -0.3 (-0.5, 0.0)
Kansas 6 *** 19.5 (18.8, 20.2) 19 (10, 30) 642 stable stable trend -0.4 (-1.0, 0.1)
Idaho 7 *** 19.4 (18.5, 20.3) 20 (8, 36) 355 stable stable trend -0.2 (-0.7, 0.4)
West Virginia 6 *** 19.2 (18.5, 20.1) 21 (11, 35) 471 stable stable trend -0.4 (-1.0, 0.3)
Louisiana 7 *** 19.2 (18.7, 19.8) 22 (13, 32) 985 falling falling trend -1.1 (-1.9, -0.2)
South Dakota 6 *** 19.2 (18.0, 20.5) 23 (6, 40) 191 stable stable trend -0.3 (-1.1, 0.5)
Ohio 6 *** 19.2 (18.8, 19.5) 24 (16, 29) 2,693 stable stable trend -0.3 (-0.6, 0.0)
Oregon 6 *** 19.0 (18.4, 19.6) 25 (14, 33) 929 falling falling trend -0.9 (-1.4, -0.3)
North Dakota 6 *** 18.9 (17.6, 20.3) 26 (7, 43) 159 stable stable trend -0.2 (-1.4, 1.1)
Montana 6 *** 18.8 (17.8, 20.0) 27 (10, 41) 245 stable stable trend -0.4 (-1.0, 0.3)
Missouri 6 *** 18.8 (18.3, 19.2) 28 (19, 35) 1,368 stable stable trend -0.1 (-0.4, 0.1)
Utah 7 *** 18.6 (17.9, 19.4) 29 (15, 39) 475 falling falling trend -1.3 (-2.3, -0.2)
Indiana 6 *** 18.6 (18.2, 19.1) 30 (20, 36) 1,399 falling falling trend -1.6 (-2.4, -0.9)
California 7 *** 18.4 (18.2, 18.6) 31 (26, 35) 7,572 falling falling trend -2.1 (-3.4, -0.8)
Arkansas 6 *** 18.2 (17.6, 18.9) 32 (21, 40) 645 stable stable trend -0.1 (-0.6, 0.4)
Georgia 7 *** 18.2 (17.8, 18.6) 33 (26, 38) 1,911 stable stable trend 0.3 (-0.1, 0.7)
Oklahoma 6 *** 18.1 (17.5, 18.7) 34 (24, 41) 793 falling falling trend -1.0 (-1.5, -0.5)
Massachusetts 7 *** 18.0 (17.6, 18.5) 35 (27, 40) 1,455 falling falling trend -7.9 (-12.9, -2.6)
Maryland 6 *** 18.0 (17.6, 18.5) 36 (26, 40) 1,216 stable stable trend 0.0 (-0.6, 0.6)
Tennessee 6 *** 17.6 (17.2, 18.0) 37 (32, 44) 1,363 falling falling trend -1.4 (-1.9, -0.9)
North Carolina 6 *** 17.6 (17.3, 18.0) 38 (33, 43) 2,035 falling falling trend -1.5 (-2.6, -0.4)
Texas 6 *** 17.3 (17.1, 17.5) 39 (37, 44) 4,579 falling falling trend -1.3 (-1.5, -1.1)
Colorado 6 *** 17.2 (16.7, 17.7) 40 (35, 46) 978 falling falling trend -1.0 (-1.4, -0.6)
Alaska 6 *** 17.1 (15.6, 18.7) 42 (19, 51) 115 falling falling trend -1.8 (-2.7, -0.9)
Virginia 6 *** 17.1 (16.7, 17.5) 41 (37, 46) 1,598 falling falling trend -0.8 (-1.4, -0.2)
Wyoming 6 *** 16.9 (15.5, 18.5) 43 (22, 51) 112 falling falling trend -1.0 (-1.8, -0.2)
South Carolina 6 *** 16.8 (16.4, 17.3) 44 (38, 47) 985 falling falling trend -0.6 (-1.0, -0.2)
Mississippi 6 *** 16.8 (16.2, 17.4) 45 (36, 48) 562 falling falling trend -1.4 (-2.1, -0.7)
Hawaii 7 *** 16.4 (15.6, 17.3) 46 (37, 51) 286 falling falling trend -2.6 (-4.9, -0.3)
Alabama 6 *** 16.2 (15.8, 16.7) 47 (42, 49) 936 stable stable trend -0.5 (-0.9, 0.0)
Arizona 6 *** 15.5 (15.1, 15.9) 48 (46, 51) 1,252 falling falling trend -0.7 (-1.1, -0.2)
Nevada 6 *** 15.3 (14.7, 16.0) 49 (46, 51) 490 stable stable trend 1.5 (-2.3, 5.4)
District of Columbia 6 *** 15.3 (14.0, 16.8) 50 (39, 51) 100 falling falling trend -6.8 (-12.6, -0.7)
New Mexico 7 *** 15.1 (14.4, 15.8) 51 (46, 51) 373 falling falling trend -1.1 (-2.2, -0.1)
Puerto Rico 6 *** 14.3 (13.8, 14.8) N/A 620 stable stable trend -0.5 (-4.7, 3.8)
Notes:
Created by statecancerprofiles.cancer.gov on 03/04/2021 5:30 am.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The 1969-2017 US Population Data File is used for SEER and NPCR incidence rates.
‡ Incidence data come from different sources. Due to different years of data availability, most of the trends are AAPCs based on APCs but some are APCs calculated in SEER*Stat. Please refer to the source for each area for additional information.

Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.
*** No Healthy People 2020 Objective for this cancer.
Healthy People 2020 Objectives provided by the Centers for Disease Control and Prevention.

# Data do not include cases diagnosed in other states for those states in which the data exchange agreement specifically prohibits the release of data to third parties.

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2017) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2019 submission.
5 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2017) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2019 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database (2001-2017) - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2019 submission).
7 Source: SEER November 2019 submission.
8 Source: Incidence data provided by the SEER Program. AAPCs are calculated by the Joinpoint Regression Program and are based on APCs. Data are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84,85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Population counts for denominators are based on Census populations as modifed by NCI. The 1969-2017 US Population Data File is used with SEER November 2019 data.

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data for United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top